Therefore, based on mounting evidence for the efficacy of targeting IGF-1R in a broad spectrum of cancers, we have determined the effects of targeting IGF-1R in pancreatic cancer in this study. This evidence concerns the gene IGF1R and familial pancreatic carcinoma.